Literature DB >> 21544390

Establishment of a continuous cell line from a human carcinoid of the small intestine (KRJ-I).

R Pfragner1, G Wirnsberger, B Niederle, A Behmel, I Rinner, A Mandl, F Wawrina, J Luo, D Adamiker, H Hoger, E Ingolic, K Schauenstein.   

Abstract

A new continuous cell line from a human malignant carcinoid of the small intestine (KRJ-I) was established. The cells showed morphological and immunocytochemical features of the tumor of origin and expressed estrogen receptors. The cells are growing as a suspension, forming multicellular aggregates and spheroids. Electron microscopy confirmed the presence of neuroendocrine granules. Dose-dependent growth inhibition was observed after incubation with 5-azacytidine. Cytogenetic analyses of the tumor of origin, the cell line KRJ-I and a liver metastasis KRJ-II revealed clonal tetraploidy and clonal loss of the Y-chromosome and chromosome 19.

Entities:  

Year:  1996        PMID: 21544390     DOI: 10.3892/ijo.8.3.513

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  21 in total

1.  Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines.

Authors:  Ignat Drozdov; Mark Kidd; Bjorn I Gustafsson; Bernhard Svejda; Richard Joseph; Roswitha Pfragner; Irvin M Modlin
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

2.  A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake.

Authors:  L Kölby; P Bernhardt; H Ahlman; B Wängberg; V Johanson; A Wigander; E Forssell-Aronsson; S Karlsson; B Ahrén; G Stenman; O Nilsson
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

3.  Microencapsulation of small intestinal neuroendocrine neoplasm cells for tumor model studies.

Authors:  Anne M Rokstad; Björn I Gustafsson; Terje Espevik; Ingunn Bakke; Roswitha Pfragner; Bernhard Svejda; Irvin M Modlin; Mark Kidd
Journal:  Cancer Sci       Date:  2012-04-27       Impact factor: 6.716

4.  Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy.

Authors:  A Kalhan; B Gharibi; M Vazquez; B Jasani; J Neal; M Kidd; I M Modlin; R Pfragner; D A Rees; J Ham
Journal:  Purinergic Signal       Date:  2011-11-27       Impact factor: 3.765

5.  A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.

Authors:  Mariano J Alvarez; Prem S Subramaniam; Laura H Tang; Adina Grunn; Mahalaxmi Aburi; Gabrielle Rieckhof; Elena V Komissarova; Elizabeth A Hagan; Lisa Bodei; Paul A Clemons; Filemon S Dela Cruz; Deepti Dhall; Daniel Diolaiti; Douglas A Fraker; Afshin Ghavami; Daniel Kaemmerer; Charles Karan; Mark Kidd; Kyoung M Kim; Hee C Kim; Lakshmi P Kunju; Ülo Langel; Zhong Li; Jeeyun Lee; Hai Li; Virginia LiVolsi; Roswitha Pfragner; Allison R Rainey; Ronald B Realubit; Helen Remotti; Jakob Regberg; Robert Roses; Anil Rustgi; Antonia R Sepulveda; Stefano Serra; Chanjuan Shi; Xiaopu Yuan; Massimo Barberis; Roberto Bergamaschi; Arul M Chinnaiyan; Tony Detre; Shereen Ezzat; Andrea Frilling; Merten Hommann; Dirk Jaeger; Michelle K Kim; Beatrice S Knudsen; Andrew L Kung; Emer Leahy; David C Metz; Jeffrey W Milsom; Young S Park; Diane Reidy-Lagunes; Stuart Schreiber; Kay Washington; Bertram Wiedenmann; Irvin Modlin; Andrea Califano
Journal:  Nat Genet       Date:  2018-06-18       Impact factor: 38.330

6.  Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines.

Authors:  Mark Kidd; Ignat Drozdov; Richard Joseph; Roswitha Pfragner; Michael Culler; Irv Modlin
Journal:  Cancer       Date:  2008-08-15       Impact factor: 6.860

7.  Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease.

Authors:  Helma Freitag; Friederike Christen; Florentine Lewens; Irina Grass; Franziska Briest; Sara Iwaszkiewicz; Britta Siegmund; Patricia Grabowski
Journal:  Neuroendocrinology       Date:  2016-08-12       Impact factor: 4.914

8.  Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids.

Authors:  Po Hien Ear; Guiying Li; Meng Wu; Ellen Abusada; Andrew M Bellizzi; James R Howe
Journal:  J Vis Exp       Date:  2019-10-14       Impact factor: 1.355

9.  Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learning.

Authors:  Ignat Drozdov; Mark Kidd; Boaz Nadler; Robert L Camp; Shrikant M Mane; Oyvind Hauso; Bjorn I Gustafsson; Irvin M Modlin
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

10.  The anti-hypertensive drug prazosin induces apoptosis in the medullary thyroid carcinoma cell line TT.

Authors:  Robert Fuchs; Gert Schwach; Anika Stracke; Nathalie Meier-Allard; Markus Absenger; Elisabeth Ingolic; Helga Susanne Haas; Roswitha Pfragner; Anton Sadjak
Journal:  Anticancer Res       Date:  2015-01       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.